Philip Morris To Acquire Vectura, Disrupting The Inhaler Market And Signalling Broader Entry Into Healthcare

摘要

1. On July 9 2021, Philip Morris International announced its offer to acquire Vectura Group.Vectura is a company active in the drug delivery space and developsand manufactures inhalers for drug delivery.2. Philip Morris has stated that it wants to diversify its core business away from cigarettesand on July 24 2021 stated its aim to remove cigarettes from the UK market by 2030.The company intends to diversify into growth markets such as healthcare and wellness.3. The entrance of Philip Morris into the drug delivery space is likely to disrupt the drugdelivery market. It indicates an increasing appetite for conglomerates to enter thehealthcare and medical device industry.